Predictive value of risk factors, additional markers and efficacy of pharmacologic treatment in cardiovascular risk reduction in patients with coronary artery disease
Selective inhibition of long chain 3-ketoacyl-Coenzyme-A-thiolase by Trimetazidine MR in coronary heart disease induced reduction of inflammatory syndrome and oxidative stress in concordance with recovery of ECG and echocardiographic changes